Breast Cancer Treatment Toremifene Citrate Anti-estrogen Steroid Powder

• Product NameBreast Cancer Treatment Toremifene Citrate Anti-estrogen Steroid Powder
  CAS No.89778-27-8
  Purity99.0%
  Min Quantity200Kilograms
  Price700~800
• View Contact Detail

• 
  Molecular Structure

Detailed Description

Breast Cancer Treatment Toremifene Citrate Anti-estrogen Steroid Powder

Toremifene Citrate
CAS number: 89778-27-8
Molecular Formula: C26H28ClNO.C6H8O7
Molecular Weight: 598.09
Density: 1.045 g/cm3
Boiling Point: 535.1 ° C at 760 mmHg
Flash Point: 277.4 ° C
Refractive index: 1,416-1,418
Solubiltiy: Freely soluble in pyridine and acetic acid, sparingly soluble in methanol, slightly soluble ethanol, very slightly soluble in waterand practically insoluble in diethyl ether
Melting point: 158~164 ° C
Assay: NLT 99.0% (HPLC)
Appearance: White or almost white powder
Package: 1kg/aluminum foil bag
Storage: Preserve in tight containers, protected from humidity, keep in dry cool place


Description:

Toremifene citrate is an oral selective estrogen receptor modulator (SERM) which helps oppose the actions of estrogen in the body. Licensed in the United States under the brand name Fareston, toremifene citrate is FDA-approved for use in advanced (metastatic) breast cancer. It is also being evaluated for prevention of prostate cancer under the brand name Acapodene.

Toremifene is also agonistic to Estrogen receptors in other tissues in the body (within the liver in particular). This means that whileToremifene will act as an anti-estrogen in breast tissue and the hypothalamus, it will act as an Estrogen within the liver. This can have beneficial impacts especially during an anabolic steroid cycle, such as improving and shifting cholesterol levels into a more favorable range.


Applications:

It has already been covered that Toremifene is a SERM, and serves to block Estrogen at various receptor sites in certain tissues within the body (breast tissue in particular). As a layman explanation, Toremifene pretends to be a ‘fake’ Estrogen that occupies Estrogen receptors within breast tissue. With these receptors occupied by Toremifene, real Estrogen cannot perform their jobs there. Toremifene does not reduce total blood plasma levels of Estrogen. In addition to being antagonistic to Estrogen receptors in breast tissue, it is also antagonistic to Estrogen at the hypothalamus gland (this essentially ‘tricks’ the hypothalamus into thinking there is little or no circulating Estrogen levels in the body, causing it to increase its manufacture of Testosterone so that it can utilize aromatization to restore these levels.

If you are interested in our products, feel free to contact us:

Skype: holybiological02
Email: holybiological02@holybiological.com

Welcome to your inquiry!

• 
• Breast Cancer Treatment Toremifene Citrate Anti-estrogen Steroid Powder